Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Design concepts of half-sandwich organoruthenium anticancer agents based on bidentate bioactive ligands
William D. J. Tremlett, David M. Goodman, Tasha R. Steel, et al.
Coordination Chemistry Reviews (2021) Vol. 445, pp. 213950-213950
Closed Access | Times Cited: 69

Showing 1-25 of 69 citing articles:

Half-Sandwich Ruthenium Arene Complexes Bearing Clinically Approved Drugs as Ligands: The Importance of Metal–Drug Synergism in Metallodrug Design
Chezhiyan Sumithaa, Mani Ganeshpandian
Molecular Pharmaceutics (2023) Vol. 20, Iss. 3, pp. 1453-1479
Closed Access | Times Cited: 40
Platinum group metal (PGM) complexes having acylthiourea ligand system as catalysts or anticancer agents
Srividya Swaminathan, Peter Jerome, Rajasekharan Jayakumari Deepak, et al.
Coordination Chemistry Reviews (2024) Vol. 503, pp. 215620-215620
Closed Access | Times Cited: 15
Piano stool Ru(II)-arene complexes having three monodentate legs: A comprehensive review on their development as anticancer therapeutics over the past decade
Srividya Swaminathan, Jebiti Haribabu, Nithya Balakrishnan, et al.
Coordination Chemistry Reviews (2022) Vol. 459, pp. 214403-214403
Closed Access | Times Cited: 58
An overview of advancement of organoruthenium(II) complexes as prospective anticancer agents
Masrat Bashir, Imtiyaz Ahmad Mantoo, Farukh Arjmand, et al.
Coordination Chemistry Reviews (2023) Vol. 487, pp. 215169-215169
Closed Access | Times Cited: 33
Organoruthenium-bipyridyl complexes – A platform for diverse chemistry and applications
Chayan Pandya, Akella Sivaramakrishna
Coordination Chemistry Reviews (2024) Vol. 504, pp. 215655-215655
Closed Access | Times Cited: 12
How does ferrocene correlate with ferroptosis? Multiple approaches to explore ferrocene-appended GPX4 inhibitors as anticancer agents
Wei Li, Jing Yu, Jing Wang, et al.
Chemical Science (2024) Vol. 15, Iss. 27, pp. 10477-10490
Open Access | Times Cited: 10
Cycloplatinated (II) Complex Based on Isoquinoline Alkaloid Elicits Ferritinophagy-Dependent Ferroptosis in Triple-Negative Breast Cancer Cells
Feng-Yang Wang, Liang-Mei Yang, Shanshan Wang, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 8, pp. 6738-6748
Closed Access | Times Cited: 9
Synthesis and Bio-evaluation of Aminoferrocene-Based Anticancer Prodrugs as Potent Ferroptosis Inducers
Qianer Zhang, Xuejing Fan, Huimei Qian, et al.
Inorganic Chemistry Frontiers (2025)
Closed Access
Synthesis, spectroscopic, quantum, thermal and kinetics, antibacterial and antifungal studies: Novel Schiff base 5-methyl-3-((5-bromosalicylidene) amino)- pyrazole and its transition metal complexes
Priyanka Devi, Kiran Singh, Bhagavati Kubavat
Results in Chemistry (2023) Vol. 5, pp. 100813-100813
Open Access | Times Cited: 16
Effect of geometric isomerism on the anticancer property of new platinum complexes with glycine derivatives as asymmetric N, O donate ligands against human cancer
Diba Kadivar, Mahboube Eslami Moghadam, Behrouz Notash
Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy (2024) Vol. 322, pp. 124809-124809
Closed Access | Times Cited: 5
In Vitro and In Vivo Anticancer Activities of Water-Soluble Ru(II)(η6-p-cymene) Complexes via Activating Apoptosis Central Regulators and Possibilities of New Antitumor Strategies in Triple Negative Breast Cancers
Shad Man, Haojie Ren, Yimiao Li, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Metal-based compounds containing selenium: An appealing approach towards novel therapeutic drugs with anticancer and antimicrobial effects
Sandra Ramos-Inza, Daniel Plano, Carmen Sanmartín
European Journal of Medicinal Chemistry (2022) Vol. 244, pp. 114834-114834
Open Access | Times Cited: 25
“Half-Sandwich” Ruthenium Complexes with Alizarin as Anticancer Agents: In Vitro and In Vivo Studies
João Honorato, Adriana P. M. Guedes, Celisnólia M. Leite, et al.
Inorganic Chemistry (2023) Vol. 62, Iss. 18, pp. 6955-6969
Closed Access | Times Cited: 12
Dichloro Ru(II)-p-cymene-1,3,5-triaza-7-phosphaadamantane (RAPTA-C): A Case Study
Srividya Swaminathan, Ramasamy Karvembu
ACS Pharmacology & Translational Science (2023) Vol. 6, Iss. 7, pp. 982-996
Closed Access | Times Cited: 12
Evaluation of heteroscorpionate ligands as scaffolds for the generation of Ruthenium(II) metallodrugs in breast cancer therapy
Elena Domínguez‐Jurado, Consuelo Ripoll, Agustín Lara‐Sánchez, et al.
Journal of Inorganic Biochemistry (2024) Vol. 253, pp. 112486-112486
Open Access | Times Cited: 4
Inhibition of NF-κB-Mediated Proinflammatory Transcription by Ru(II) Complexes of Anti-Angiogenic Ligands in Triple-Negative Breast Cancer
Ayan Chakraborty, Shilpendu Ghosh, Manas Pratim Chakraborty, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 7, pp. 5902-5923
Closed Access | Times Cited: 4
Antifungal and Antibacterial Activity of two new Ni(II) Complexes of a Pyrazole-Appended Thiophene containing bidentate Schiff-base ligand: Synthesis, Spectroscopy and Crystal Structures
Suman Mandal, Ankika Bhakat, Saikat Banerjee, et al.
Journal of Molecular Structure (2024) Vol. 1313, pp. 138688-138688
Closed Access | Times Cited: 4
Revisiting metallodrugs for the treatment of skin cancers
Carlos Marrote Manzano, Douglas Hideki Nakahata, Raphael Enoque Ferraz de Paiva
Coordination Chemistry Reviews (2022) Vol. 462, pp. 214506-214506
Open Access | Times Cited: 21
Antitumor studies evaluation of triphenylphosphine ruthenium complexes with 5,7-dihalo-substituted-8-quinolinoline targeting mitophagy pathways
Zhenfeng Wang, Xiaoqiong Huang, Run-Chun Wu, et al.
Journal of Inorganic Biochemistry (2023) Vol. 248, pp. 112361-112361
Closed Access | Times Cited: 11
Synthesis, spectroscopic characterizations, single crystal X-ray analysis, DFT calculations, in vitro biological evaluation and in silico evaluation studies of thiosemicarbazones based 1,3,4-thiadiazoles
Vishnunarayanan Namboothiri Vadakkedathu Palakkeezhillam, Jebiti Haribabu, Vipin Manakkadan, et al.
Journal of Molecular Structure (2022) Vol. 1273, pp. 134309-134309
Closed Access | Times Cited: 16
Coordination of Ru(II)-Arene Fragments to Dipyridophenazine Ligands Leads to the Modulation of Their In Vitro and In Vivo Anticancer Activity
Stefan Nikolić, Jemma Arakelyan, Владимир Кушнарев, et al.
Inorganic Chemistry (2023) Vol. 62, Iss. 21, pp. 8188-8199
Closed Access | Times Cited: 8
NRF2 and Bip Interconnection Mediates Resistance to the Organometallic Ruthenium-Cymene Bisdemethoxycurcumin Complex Cytotoxicity in Colon Cancer Cells
Alessia Garufi, Riccardo Pettinari, F. Marchetti, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 593-593
Open Access | Times Cited: 7
Investigating the anticancer potential of 4-phenylthiazole derived Ru(ii) and Os(ii) metalacycles
Paul Getreuer, Laura Marretta, Emine Toyoglu, et al.
Dalton Transactions (2024) Vol. 53, Iss. 12, pp. 5567-5579
Open Access | Times Cited: 2
A multifaceted approach towards organometallic anticancer agent development
Christian G. Hartinger
Journal of Organometallic Chemistry (2024) Vol. 1012, pp. 123144-123144
Open Access | Times Cited: 2
Advances in anticancer alkaloid-derived metallo-chemotherapeutic agents in the last decade: Mechanism of action and future prospects
Mohammad Fawad Ansari, Huzaifa Yasir Khan, Sartaj Tabassum, et al.
Pharmacology & Therapeutics (2022) Vol. 241, pp. 108335-108335
Closed Access | Times Cited: 12
Page 1 - Next Page

Scroll to top